Back to search

Article

Control of CDH1 and IDH1mut glioblastoma cell cycle by D-2- hydroxyglutarate

2024-04-19

Abstract excerpt

Glioblastoma (GBM) is a prevalent and lethal primary brain tumor. Patients with the IDH1 R132H (isocitrate dehydrogenase 1) mutation exhibit extended survival and aneuploidy, yet the underlying mechanisms are unclear. Here, we reveal that the accumulation of D-2-hydroxyglutarate (2-HG) produced by IDH1 R132H mutation induces the degradation of Fizzy-related protein1(FZR1 or CDH1) by inhibiting prolyl hydroxylase E...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
65d30715-3069-5d9d-b3b1-0d03a71565be
DOI
10.21203/rs.3.rs-4240423/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Control of CDH1 and IDH1mut glioblastoma cell cycle by D-2- hydroxyglutarateDOI 10.21203/rs.3.rs-4240423/v1
Select a neighboring publication to make it the new centre.